Pluristem Therapeutics Inc., a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient cell therapy products for a variety of disorders, announced today that it will be presenting the Company's development program at 9 am on Wednesday, April 22, 2009 at the Stock Exchange in Tel Aviv, Israel.
Pluristem Therapeutics to present at the Tel-Aviv Stock Exchange